Status:

COMPLETED

The Impact of Oxytocin on the Neurobiology of Anorexia Nervosa

Lead Sponsor:

University of Minnesota

Collaborating Sponsors:

Klarman Foundation

Conditions:

Anorexia Nervosa

Eligibility:

FEMALE

18+ years

Phase:

EARLY_PHASE1

Brief Summary

This study will use a randomized, controlled, double-blind design involving the administration of intranasal oxytocin (INOT) or placebo to adults with anorexia nervosa, restricting subtype and age-mat...

Detailed Description

The primary objective of this investigation is to determine the impact of oxytocin (OT), a peptide hormone that influences social affiliation, on socioemotional neural circuitry and eating disorder be...

Eligibility Criteria

Inclusion

  • All participants:
  • Age \> 18 years old
  • Female (given the potential sex differences to endogenous OT to INOT)
  • Ability to read and speak in English
  • Right-handed
  • Anorexia nervosa participants:
  • DSM-5 diagnosis of AN, restricting subtype (established by the SCID-5-RV),
  • BMI \< 18.5 kg/m2 within the past month

Exclusion

  • All participants
  • <!-- -->
  • Medical instability or current pregnancy or lactation
  • Current substance use disorder, psychosis, or bipolar-I disorder
  • Contraindication for fMRI (e.g., implanted metal)
  • History of neurological disorder/injury (e.g., stroke; head injury with \> 10 minutes loss of consciousness)
  • Food allergy that cannot be accommodated through substitutions to the laboratory test meal
  • Lacking capacity to consent
  • Contraindications for intranasal oxytocin administration
  • Acute suicidality
  • Psychoactive medication (e.g., antidepressants, antipsychotics)
  • Exclusion for participants without anorexia nervosa
  • <!-- -->
  • Current DSM-5 Axis-I diagnosis or current or past eating disorder diagnosis
  • BMI \< 19.0

Key Trial Info

Start Date :

September 25 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 30 2021

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT03414112

Start Date

September 25 2018

End Date

April 30 2021

Last Update

February 11 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Minnesota - Dept of Psychiatry

Minneapolis, Minnesota, United States, 55454